| Literature DB >> 34365796 |
Kosuke Noguchi1, Momoko Obuki1, Haruka Sumi1, Merlin Klußmann2, Kenta Morimoto1, Shinya Nakai1, Takuya Hashimoto3, Daisuke Fujiwara1, Ikuo Fujii1, Eiji Yuba3, Tomoka Takatani-Nakase4,5, Ines Neundorf2, Ikuhiko Nakase1,6.
Abstract
The antimicrobial protein CAP18 (approximate molecular weight: 18 000), which was first isolated from rabbit granulocytes, comprises a C-terminal fragment that has negatively charged lipopolysaccharide binding activity. In this study, we found that CAP18 (106-121)-derived (sC18)2 peptides have macropinocytosis-inducible biological functions. In addition, we found that these peptides are highly applicable for use as extracellular vesicle (exosomes, EV)-based intracellular delivery, which is expected to be a next-generation drug delivery carrier. Here, we demonstrate that dimerized (sC18)2 peptides can be easily introduced on EV membranes when modified with a hydrophobic moiety, and that they show high potential for enhanced cellular uptake of EVs. By glycosaminoglycan-dependent induction of macropinocytosis, cellular EV uptake in targeted cells was strongly increased by the peptide modification made to EVs, and intriguingly, our herein presented technique is efficiently applicable for the cytosolic delivery of the biologically cell-killing functional toxin protein, saporin, which was artificially encapsulated in the EVs by electroporation, suggesting a useful technique for EV-based intracellular delivery of biofunctional molecules.Entities:
Keywords: cell-penetrating peptides; exosomes; extracellular vesicles; intracellular delivery; macropinocytosis
Mesh:
Substances:
Year: 2021 PMID: 34365796 DOI: 10.1021/acs.molpharmaceut.1c00244
Source DB: PubMed Journal: Mol Pharm ISSN: 1543-8384 Impact factor: 4.939